Form 8-K - Current report:
SEC Accession No. 0001193125-20-138276
Filing Date
2020-05-11
Accepted
2020-05-11 07:36:52
Documents
59
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d929610d8k.htm   iXBRL 8-K 29135
2 EX-99.1 d929610dex991.htm EX-99.1 82329
3 EX-99.2 d929610dex992.htm EX-99.2 49402
7 GRAPHIC g929610ex99_2s10g1.jpg GRAPHIC 216977
8 GRAPHIC g929610ex99_2s11g1.jpg GRAPHIC 267597
9 GRAPHIC g929610ex99_2s12g1.jpg GRAPHIC 154284
10 GRAPHIC g929610ex99_2s13g1.jpg GRAPHIC 230266
11 GRAPHIC g929610ex99_2s14g1.jpg GRAPHIC 210328
12 GRAPHIC g929610ex99_2s15g1.jpg GRAPHIC 217740
13 GRAPHIC g929610ex99_2s16g1.jpg GRAPHIC 154725
14 GRAPHIC g929610ex99_2s17g1.jpg GRAPHIC 286427
15 GRAPHIC g929610ex99_2s18g1.jpg GRAPHIC 135530
16 GRAPHIC g929610ex99_2s19g1.jpg GRAPHIC 238748
17 GRAPHIC g929610ex99_2s1g1.jpg GRAPHIC 316258
18 GRAPHIC g929610ex99_2s20g1.jpg GRAPHIC 220756
19 GRAPHIC g929610ex99_2s21g1.jpg GRAPHIC 223678
20 GRAPHIC g929610ex99_2s22g1.jpg GRAPHIC 332138
21 GRAPHIC g929610ex99_2s23g1.jpg GRAPHIC 101061
22 GRAPHIC g929610ex99_2s24g1.jpg GRAPHIC 250362
23 GRAPHIC g929610ex99_2s25g1.jpg GRAPHIC 334754
24 GRAPHIC g929610ex99_2s26g1.jpg GRAPHIC 208004
25 GRAPHIC g929610ex99_2s27g1.jpg GRAPHIC 159841
26 GRAPHIC g929610ex99_2s28g1.jpg GRAPHIC 189424
27 GRAPHIC g929610ex99_2s29g1.jpg GRAPHIC 111049
28 GRAPHIC g929610ex99_2s2g1.jpg GRAPHIC 407337
29 GRAPHIC g929610ex99_2s30g1.jpg GRAPHIC 267609
30 GRAPHIC g929610ex99_2s31g1.jpg GRAPHIC 252604
31 GRAPHIC g929610ex99_2s32g1.jpg GRAPHIC 297557
32 GRAPHIC g929610ex99_2s33g1.jpg GRAPHIC 183509
33 GRAPHIC g929610ex99_2s34g1.jpg GRAPHIC 227349
34 GRAPHIC g929610ex99_2s35g1.jpg GRAPHIC 227048
35 GRAPHIC g929610ex99_2s36g1.jpg GRAPHIC 206771
36 GRAPHIC g929610ex99_2s37g1.jpg GRAPHIC 102245
37 GRAPHIC g929610ex99_2s38g1.jpg GRAPHIC 279639
38 GRAPHIC g929610ex99_2s39g1.jpg GRAPHIC 256855
39 GRAPHIC g929610ex99_2s3g1.jpg GRAPHIC 182073
40 GRAPHIC g929610ex99_2s40g1.jpg GRAPHIC 294145
41 GRAPHIC g929610ex99_2s41g1.jpg GRAPHIC 266640
42 GRAPHIC g929610ex99_2s42g1.jpg GRAPHIC 274010
43 GRAPHIC g929610ex99_2s43g1.jpg GRAPHIC 186076
44 GRAPHIC g929610ex99_2s44g1.jpg GRAPHIC 288430
45 GRAPHIC g929610ex99_2s4g1.jpg GRAPHIC 216746
46 GRAPHIC g929610ex99_2s5g1.jpg GRAPHIC 112308
47 GRAPHIC g929610ex99_2s6g1.jpg GRAPHIC 284864
48 GRAPHIC g929610ex99_2s7g1.jpg GRAPHIC 311634
49 GRAPHIC g929610ex99_2s8g1.jpg GRAPHIC 257736
50 GRAPHIC g929610ex99_2s9g1.jpg GRAPHIC 389195
51 GRAPHIC g929610g0511030708754.jpg GRAPHIC 6239
  Complete submission text file 0001193125-20-138276.txt   14557422

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20200511.xsd EX-101.SCH 3090
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20200511_lab.xml EX-101.LAB 17305
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20200511_pre.xml EX-101.PRE 10943
55 EXTRACTED XBRL INSTANCE DOCUMENT d929610d8k_htm.xml XML 3272
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 20862636
SIC: 2834 Pharmaceutical Preparations